Nationwide trends in deaths involving renal failure and pulmonary vascular disease in the United States from 1999 to 2024 using CDC WONDER Data

Pulmonary vascular disease (PVD) (pulmonary hypertension [PH] and pulmonary heart disease [PHD]) has pathophysiological similarities with renal failure, which are important to cardiovascular death. There are no comprehensive national mortality trends at this intersection. This study looks at the trends in deaths involving renal failure and pulmonary vascular disease from 26 years across sex, race, ethnicity, region and urbanization. Data from CDC WONDER (Multiple Cause of Death) were analyzed for a primary cohort (1999–2020, n = 27,672) and a recent-period (sensitivity) analysis (2018–2024, n = 14,336), not an independent cohort, as this period overlaps with 1999–2020. The underlying condition was renal failure (N17–N19) as the underlying cause of death, and pulmonary vascular disease codes (I26–I28) were recorded as multiple-cause-of-death (contributing) mentions on the same certificate. The Annual Percent Change (APC) and 95% confidence intervals (CIs) were calculated using JoinPoint regression program. From 1999 to 2020, mortality increased significantly in females (APC + 2.14%) and males (+ 1.54%). The rise was largest for the Hispanic (+ 2.94%) and the highest number of deaths occurred in the South ( n = 10,361). In the 2018–2024 recent-period analysis, accelerated trends appeared: females (APC + 5.14%), males (+ 4.15%), and the Midwest (+ 6.10%). Most deaths were due to secondary pulmonary hypertension (75.2%). The number of deaths due to renal failure and pulmonary vascular disease are increasing, particularly between 2018 and 2024. When data are aggregated, there are increasing racial/ethnic and rural disparities. Results support targeted screening and a multi-disciplinary approach to cardio-renal-pulmonary axis and equity focused public health interventions. These explanations are hypothesis-generating and require further studies with individual-level clinical and socioeconomic data.

Authors

Institutions

Publication Details

Journal
Discover Public Health
Published
2026-10-06
DOI
https://doi.org/10.1186/s12982-026-03111-6
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nationwide trends in deaths involving renal failure and pulmonary vascular disease in the United States from 1999 to 2024 using CDC WONDER Data

ShariqA Khan, Amina Asif, Kanza Riaz, Muhammad Dawood Nazir et al.
Discover Public Health
Pulmonary Hypertension Research and Treatments
article

Nationwide trends in deaths involving renal failure and pulmonary vascular disease in the United States from 1999 to 2024 using CDC WONDER Data

ShariqA Khan, Amina Asif, Kanza Riaz, Muhammad Dawood Nazir, Hamna Khalid, Maryam Amjad, Syed Arshman Hussain, Biniam Jemjem Adinew
article en

Abstract

Pulmonary vascular disease (PVD) (pulmonary hypertension [PH] and pulmonary heart disease [PHD]) has pathophysiological similarities with renal failure, which are important to cardiovascular death. There are no comprehensive national mortality trends at this intersection. This study looks at the trends in deaths involving renal failure and pulmonary vascular disease from 26 years across sex, race, ethnicity, region and urbanization. Data from CDC WONDER (Multiple Cause of Death) were analyzed for a primary cohort (1999–2020, n = 27,672) and a recent-period (sensitivity) analysis (2018–2024, n = 14,336), not an independent cohort, as this period overlaps with 1999–2020. The underlying condition was renal failure (N17–N19) as the underlying cause of death, and pulmonary vascular disease codes (I26–I28) were recorded as multiple-cause-of-death (contributing) mentions on the same certificate. The Annual Percent Change (APC) and 95% confidence intervals (CIs) were calculated using JoinPoint regression program. From 1999 to 2020, mortality increased significantly in females (APC + 2.14%) and males (+ 1.54%). The rise was largest for the Hispanic (+ 2.94%) and the highest number of deaths occurred in the South ( n = 10,361). In the 2018–2024 recent-period analysis, accelerated trends appeared: females (APC + 5.14%), males (+ 4.15%), and the Midwest (+ 6.10%). Most deaths were due to secondary pulmonary hypertension (75.2%). The number of deaths due to renal failure and pulmonary vascular disease are increasing, particularly between 2018 and 2024. When data are aggregated, there are increasing racial/ethnic and rural disparities. Results support targeted screening and a multi-disciplinary approach to cardio-renal-pulmonary axis and equity focused public health interventions. These explanations are hypothesis-generating and require further studies with individual-level clinical and socioeconomic data.

Discover Public HealthVol. 23(1)
University of Wah (PK), St. Paul's Hospital Millennium Medical College (ET), Wah Medical College (PK)
Openalex Percentile: Top 12%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.